Chris Richardson, CEO of SafeHeal, will be presenting an overview of the benefits of Colovac to strategic partners....
SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer
Breakthrough device promises significantly improved patient recovery after colorectal surgery....
SafeHeal Announces Successful Launch of IDE Study for Colovac Endoluminal Bypass Sheath
Apr 01, 2022 - Breakthrough device promises significantly improved patient recovery after colorectal surgery....
SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath
Apr 03, 2019 - SafeHeal, a leading innovator in the field of digestive surgery, announces today that its unique Colovac bypass sheath has received the...
SafeHeal Completes First-in-Human Clinical Study of Endoluminal Bypass Sheath
Jan 11, 2019 - SafeHeal, an innovator in the field of digestive surgery, has concluded its first-in-human clinical study for its novel Colovac bypass ...
SAFEHEAL starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy
Jan 29, 2018 -The study will evaluate safety and efficacy of the Colovac bypass device for ostomy-free anastomosis protection following colorectal sur...
SafeHeal Appoints Dr. Karl Blohm as CEO to Prepare for Launch and Commercialization
Apr 03, 2019 - SafeHeal, a leading innovator in the field of digestive surgery, announces today that its unique Colovac bypass sheath has received the...